Imclone Systems Inc - IMCL- Profile

Home » Directory » Pharmaceuticals & Biotechnology » Critical Therapies » Cancer » Imclone Systems Inc » Profile

Website: http://www.imclone.com

Phone: +1 212 645-1405
Address:
180 Varick Street
New York, NEW YORK 10014

Company Description
Imclone Systems Inc. The Group's principal activity is to conduct research and develop therapeutic products for the treatment of cancer and cancer related disorders. The Group's product, ERBITUX(TM) is a therapeutic monoclonal antibody that inhibits stimulation of Epidermal Growth Factor (EGF) receptor upon which certain solid tumors depend in order to grow. The Group also develops the inhibitors of angiogenesis, which can be used to treat various kinds of cancer and other diseases. The Group performs ongoing research which includes ongoing clinical programs of growth factor blockers, other tumor cell growth inhibitors and angiogenesis inhibitors. Develops therapeutic productions and portfolio of targeted biologic treatments designed for the treatment of cancer
Key People
Chairman Alexander J. Denner
Senior Vice President Finance & Chief Financial Officer Ana I. Stancic
Vice President, General Counsel & Secretary Erik D. Ramanathan

Related Business Topics
click here
A-Z Imclone Systems Inc Provider Directory
0-9 | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
I
Imclone Systems
www.imclone.com
Breaking News
Reuters - November 13, 2009 7:10 AM
CHICAGO--(Business Wire)-- Fitch Ratings has affirmed Eli Lilly and Co.'s (Eli Lilly) ratings as follows: --Issuer Default Rating (IDR) at 'A+'; --Bank loan at 'A+'; --Senior unsecured debt at 'A+'; --Short-term IDR at 'F1'; --Commercial paper at 'F1'. ...
Forbes.com - November 13, 2009 7:04 AM
BusinessWire - Fitch Ratings has affirmed Eli Lilly and Co.'s (Eli Lilly) ratings as follows: --Issuer Default Rating (IDR) at 'A+'; --Bank loan at 'A+'; --Senior unsecured debt at 'A+'; --Short-term IDR at 'F1'; --Commercial paper at 'F1'. The Rating ...
Reuters - September 11, 2009 6:55 AM
WOBURN, Mass., Sept. 11 /PRNewswire/ -- The Center for Business Intelligence (CBI) is pleased to announce the full agenda for their 2nd West Coast Forum on Clinical Supply Chain Management. The conference takes place in Burlingame, CA, on October 28-29, ...
CNBC - September 11, 2009 6:17 AM
WOBURN, Mass., Sept 11, 2009 /PRNewswire via COMTEX/ -- The Center for Business Intelligence (CBI) is pleased to announce the full agenda for their 2nd West Coast Forum on Clinical Supply Chain Management. The conference takes place in Burlingame, CA, on ...
Forbes.com - September 11, 2009 6:04 AM
, 8:26 AM ET WOBURN, Mass., Sept. 11 /PRNewswire/ -- The Center for Business Intelligence (CBI) is pleased to announce the full agenda for their 2nd West Coast Forum on Clinical Supply Chain Management . The conference takes place in Burlingame, CA, on ...

More Imclone Systems News

Cancer Treatment Center
In Loma Linda, CA W/ Outstanding Reputation. Request More Info Here!
LomaLindaHealth.org/CancerTreatment
Chemotherapy Information
Find the Answers You're Looking for to Your Chemotherapy Questions.
www.Chemotherapy.com
Neulasta® (pegfilgrastim)
Get the Facts About Neulasta by Visiting the Official Site Now.
www.Neulasta.com

Overview  |  Profile  |  News  |  Quote & Financials